Global Research and Development Collaboration

In addition to its own research programs, BioNet actively in-licenses technologies and participates into research and development collaborations. We combine a broad range of expertise in process development, analytical and animal testing and clinical evaluation, along with significant experience in patenting and business to assess market opportunities and devise an optimised commercialisation strategy for each individual technology.

We flexibly and pragmatically design agreements with commercial entities to provide them with a strong incentive to evaluate, develop and exploit the licensed technology. We ensure that the licensees have the technical expertise and the commercial capabilities to take licensed technology to market including the securing of regulatory approvals.

Closeup of scientist doctor looking into medical microscope analyzing blood sample during scientific experiment in biochemistry laboratory. Researcher man developing vaccine against covid19

Technology Transfer and Manufacturing Partnerships

Strong partnerships are the core of any trusted network.
Fostering vaccine self-reliance, BioNet can propose technology transfers for the production of vaccines, such as Hib and Recombinant pertussis but also for viral vaccines such as HBV and HPV.

Over the past decades, BioNet has also built strategic collaborative ties with and between vaccine manufacturers around the globe for the bulk supply, formulation and manufacturing of polio, rabies, influenza, hepatitis and DTP vaccines.

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

Marketing & Distribution Network

Through marketing and distribution partnerships, BioNet has built a vaccine-specialized sales and marketing network around the world. Our network of clients includes distributors, government organizations, NGO but also vaccine manufacturers.

We can offer to manufacturers a unique Market reach in the emerging world by adding their vaccines to our product portfolio.
Our extensive marketing experience and network expertise enable us to identify the right strategy for each licensed vaccine to rapidly penetrate market in every countries through market segmentation, product positioning, competitive analysis and partnership opportunities.

-International Marketing Agreements
-Strategic Supply Alliances (bulk)
-Clinical Development Collaborations (from Phase I to IV clinical trials)
-Public Private Partnerships (South Africa)